Viewing Study NCT01885195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-02-23 @ 11:35 AM
Study NCT ID: NCT01885195
Status: COMPLETED
Last Update Posted: 2021-02-21
First Post: 2013-06-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: MEK162 for Patients With RAS/RAF/MEK Activated Tumors
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor and Hematologic Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, … View